<?xml version="1.0" encoding="UTF-8"?>
<aid:result xmlns:aid="http://aid.vle.org" total="73" query="+(+content:&quot;transmembrane proteins&quot; +content:amyloid) +(year:2012^10.0 year:2011^10.0 year:2010^10.0 year:2009^10.0 year:2008^9.0 year:2007^8.0 year:2007^7.0 year:2006^6.0 year:2005^5.0 year:2004^4.0 year:2003^3.0 year:2002^2.0 year:2002)" time="1">
  <doc url="http://dev.adaptivedisclosure.org:80/search/item/17368826?index=MedLine" rank="1" score="0.2182844579219818115234375">
    <field name="PMID">
      <value>17368826</value>
    </field>
    <field name="year">
      <value>2007</value>
    </field>
    <field name="PT">
      <value>Journal Article</value>
    </field>
    <field name="PT">
      <value>Research Support, Non-U.S. Gov&amp;quot;t</value>
    </field>
    <field name="title">
      <value>Notch1 intracellular domain suppresses APP intracellular domain-Tip60-Fe65 complex mediated signaling through physical interaction.</value>
    </field>
    <field name="content">
      <value>The amyloid beta-precursor protein (APP) and the Notch receptor are both type 1 integral transmembrane proteins, and both are cleaved by presenilin-dependent gamma-secretase activity. In this study, we have demonstrated that the Notch intracellular domain (Notch1-IC) suppresses APP-intracellular domain (AICD)-mediated ROS generation and cell death after being processed by gamma secretase. Notch1-IC physically interacts with AICD, Fe65, and Tip60, thereby disrupting the association of the AICD-Fe65-Tip60 trimeric transcription activator complex in AICD signaling. AICD-Fe65-Tip60 mediated reactive oxygen species generation was found to be suppressed by Notch1-IC. Furthermore, AICD-Fe65-Tip60 was shown to mediate cell death in human neuroblastoma cells, and the overexpression of Notch1-IC inhibited cell death induced by AICD-Fe65-Tip60. Collectively, our findings indicate that Notch1-IC plays the role of a negative regulator in AICD signaling via the disruption of the AICD-Fe65-Tip60 trimeric complex.</value>
    </field>
    <field name="author">
      <value>Sun-Yee Kim</value>
    </field>
    <field name="author">
      <value>Mi-Yeon Kim</value>
    </field>
    <field name="author">
      <value>Jung-Soon Mo</value>
    </field>
    <field name="author">
      <value>Hee-Sae Park</value>
    </field>
    <field name="modified">
      <value>2/14/09</value>
    </field>
    <field name="LuceneDocID">
      <value>3503107</value>
    </field>
  </doc>
  <doc url="http://dev.adaptivedisclosure.org:80/search/item/17596450?index=MedLine" rank="2" score="0.2182844579219818115234375">
    <field name="PMID">
      <value>17596450</value>
    </field>
    <field name="year">
      <value>2007</value>
    </field>
    <field name="PT">
      <value>Journal Article</value>
    </field>
    <field name="PT">
      <value>Research Support, N.I.H., Extramural</value>
    </field>
    <field name="PT">
      <value>Research Support, Non-U.S. Gov&amp;quot;t</value>
    </field>
    <field name="title">
      <value>Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer&amp;quot;s disease-linked mutant presenilin 1.</value>
    </field>
    <field name="content">
      <value>Presenilins (PS) play a central role in gamma-secretase-mediated processing of beta-amyloid precursor protein (APP) and numerous type I transmembrane proteins. Expression of mutant PS1 variants causes familial forms of Alzheimer&amp;quot;s disease (FAD). In cultured mammalian cells that express FAD-linked PS1 variants, the intracellular trafficking of several type 1 membrane proteins is altered. We now report that the anterograde fast axonal transport (FAT) of APP and Trk receptors is impaired in the sciatic nerves of transgenic mice expressing two independent FAD-linked PS1 variants. Furthermore, FAD-linked PS1 mice exhibit a significant increase in phosphorylation of the cytoskeletal proteins tau and neurofilaments in the spinal cord. Reductions in FAT and phosphorylation abnormalities correlated with motor neuron functional deficits. Together, our data suggests that defects in anterograde FAT may underlie FAD-linked PS1-mediated neurodegeneration through a mechanism involving impairments in neurotrophin signaling and synaptic dysfunction.</value>
    </field>
    <field name="author">
      <value>Orly Lazarov</value>
    </field>
    <field name="author">
      <value>Gerardo A Morfini</value>
    </field>
    <field name="author">
      <value>Gustavo Pigino</value>
    </field>
    <field name="author">
      <value>Archana Gadadhar</value>
    </field>
    <field name="author">
      <value>Xiangjun Chen</value>
    </field>
    <field name="author">
      <value>John Robinson</value>
    </field>
    <field name="author">
      <value>Hanson Ho</value>
    </field>
    <field name="author">
      <value>Scott T Brady</value>
    </field>
    <field name="author">
      <value>Sangram S Sisodia</value>
    </field>
    <field name="modified">
      <value>2/14/09</value>
    </field>
    <field name="LuceneDocID">
      <value>7124659</value>
    </field>
  </doc>
  <doc url="http://dev.adaptivedisclosure.org:80/search/item/17988153?index=MedLine" rank="3" score="0.2080340683460235595703125">
    <field name="PMID">
      <value>17988153</value>
    </field>
    <field name="year">
      <value>2007</value>
    </field>
    <field name="PT">
      <value>Journal Article</value>
    </field>
    <field name="PT">
      <value>Research Support, Non-U.S. Gov&amp;quot;t</value>
    </field>
    <field name="title">
      <value>Overexpression of human CRB1 or related isoforms, CRB2 and CRB3, does not regulate the human presenilin complex in culture cells.</value>
    </field>
    <field name="content">
      <value>The presenilin proteins (PS1 and PS2) with their partners (NCT, Aph1, and Pen2) are the major components of the high molecular weight gamma-secretase complex which facilitates the intramembraneous cleavage of various type 1 transmembrane proteins, including the amyloid-beta precursor protein (APP) and the Notch receptor. Additional gamma-secretase complex components may be involved in regulation of its activity and specificity. A recent investigation indicated that the Crumbs protein is a negative regulator of Notch signaling and may act by repressing gamma/epsilon-secretase activity in Drosophila [Herranz, H., Stamataki, E., Feiguin, F., and Milan, M. (2006) EMBO Rep. 7, 297-302]. To address this question, we investigated potential functional interactions between the human Crumbs homologues (CRB1, CRB2, and CRB3) and presenilin complexes which mediate gamma/epsilon-secretase cleavage of APP and Notch. We found no evidence for direct interaction between CRB1, CRB2, or CRB3 and presenilin complex components. Furthermore, overexpression of human CRB1 and related isoforms, CRB2 and CRB3, had no effect on the levels of presenilin complex components, on NCT maturation or on PS endoproteolysis, and did not alter Abeta AICD or NICD production. These results suggest that, in mammalian cells at least, Crumbs is unlikely to be a significant direct modulator of presenilin-dependent gamma/epsilon-secretase activity.</value>
    </field>
    <field name="author">
      <value>RaphaÃ«lle Pardossi-Piquard</value>
    </field>
    <field name="author">
      <value>Fusheng Chen</value>
    </field>
    <field name="author">
      <value>Nancy F Silva-Gagliardi</value>
    </field>
    <field name="author">
      <value>Michael Szego</value>
    </field>
    <field name="author">
      <value>Roderick McInnes</value>
    </field>
    <field name="author">
      <value>C Jane McGlade</value>
    </field>
    <field name="author">
      <value>Peter St George-Hyslop</value>
    </field>
    <field name="author">
      <value>Paul E Fraser</value>
    </field>
    <field name="modified">
      <value>2/14/09</value>
    </field>
    <field name="LuceneDocID">
      <value>4659049</value>
    </field>
  </doc>
  <doc url="http://dev.adaptivedisclosure.org:80/search/item/17288597?index=MedLine" rank="4" score="0.20290696620941162109375">
    <field name="PMID">
      <value>17288597</value>
    </field>
    <field name="year">
      <value>2007</value>
    </field>
    <field name="PT">
      <value>Journal Article</value>
    </field>
    <field name="title">
      <value>Dual roles of the transmembrane protein p23/TMP21 in the modulation of amyloid precursor protein metabolism.</value>
    </field>
    <field name="content">
      <value>BACKGROUND: Alzheimer&amp;quot;s disease (AD) is characterized by cerebral deposition of beta-amyloid (Abeta) peptides. Abeta is released from ectodomain cleaved amyloid precursor protein (APP) via intramembranous proteolysis by gamma-secretase, a complex consisting of presenilin and a few other proteins. p23/TMP21, a member of the p24 family type I transmembrane proteins, was recently identified as a presenilin complex component capable of modulating gamma-secretase cleavage. The p24 family proteins form oligomeric complexes and regulate vesicular trafficking in the early secretory pathway, but their role in APP trafficking has not been investigated. RESULTS: Here, we report that siRNA-mediated depletion of p23 in N2a neuroblastoma and HeLa cells produces concomitant knockdown of additional p24 family proteins and increases secretion of sAPP. Furthermore, intact cell and cell-free Abeta production increases following p23 knockdown, similar to data reported earlier using HEK293 cells. However, we find that p23 is not present in mature gamma-secretase complexes isolated using an active-site gamma-secretase inhibitor. Depletion of p23 and expression of a familial AD-linked PS1 mutant have additive effects on Abeta42 production. Knockdown of p23 expression confers biosynthetic stability to nascent APP, allowing its efficient maturation and surface accumulation. Moreover, immunoisolation analyses show decrease in co-residence of APP and the APP adaptor Mint3. Thus, multiple lines of evidence indicate that p23 function influences APP trafficking and sAPP release independent of its reported role in gamma-secretase modulation. CONCLUSION: These data assign significance to p24 family proteins in regulating APP trafficking in the continuum of bidirectional transport between the ER and Golgi, and ascribe new relevance to the regulation of early trafficking in AD pathogenesis.</value>
    </field>
    <field name="author">
      <value>Kulandaivelu S Vetrivel</value>
    </field>
    <field name="author">
      <value>Ping Gong</value>
    </field>
    <field name="author">
      <value>James W Bowen</value>
    </field>
    <field name="author">
      <value>Haipeng Cheng</value>
    </field>
    <field name="author">
      <value>Ying Chen</value>
    </field>
    <field name="author">
      <value>Meghan Carter</value>
    </field>
    <field name="author">
      <value>Phuong D Nguyen</value>
    </field>
    <field name="author">
      <value>Lisa Placanica</value>
    </field>
    <field name="author">
      <value>Felix T Wieland</value>
    </field>
    <field name="author">
      <value>Yue-Ming Li</value>
    </field>
    <field name="author">
      <value>Maria Z Kounnas</value>
    </field>
    <field name="author">
      <value>Gopal Thinakaran</value>
    </field>
    <field name="modified">
      <value>2/14/09</value>
    </field>
    <field name="LuceneDocID">
      <value>5461712</value>
    </field>
  </doc>
  <doc url="http://dev.adaptivedisclosure.org:80/search/item/17556541?index=MedLine" rank="5" score="0.1977836787700653076171875">
    <field name="PMID">
      <value>17556541</value>
    </field>
    <field name="year">
      <value>2007</value>
    </field>
    <field name="PT">
      <value>Journal Article</value>
    </field>
    <field name="PT">
      <value>Research Support, N.I.H., Extramural</value>
    </field>
    <field name="PT">
      <value>Research Support, Non-U.S. Gov&amp;quot;t</value>
    </field>
    <field name="title">
      <value>Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression.</value>
    </field>
    <field name="content">
      <value>Presenilins (PS, PS1/PS2) are necessary for the proteolytic activity of gamma-secretase, which cleaves multiple type I transmembrane proteins including Alzheimer&amp;quot;s beta-amyloid precursor protein (APP), Notch, ErbB4, etc. Cleavage by PS/gamma-secretase releases the intracellular domain (ICD) of its substrates. Notch ICD translocates into the nucleus to regulate expression of genes important for development. However, the patho/physiological role of other ICDs, especially APP ICD (AICD), in regulating gene expression remains controversial because evidence supporting this functionality stems mainly from studies performed under supraphysiological conditions. EGF receptor (EGFR) is up-regulated in a wide variety of tumors and hence is a target for cancer therapeutics. Abnormal expression/activation of EGFR contributes to keratinocytic carcinomas, and mice with reduced PS dosages have been shown to develop skin tumors. Here we demonstrate that the levels of PS and EGFR in the skin tumors of PS1(+/-)/ PS2(-/-) mice and the brains of PS1/2 conditional double knockout mice are inversely correlated. Deficiency in PS/gamma-secretase activity or APP expression results in a significant increase of EGFR in fibroblasts. Importantly, we show that AICD mediates transcriptional regulation of EGFR. Furthermore, we provide in vivo evidence demonstrating direct binding of endogenous AICD to the EGFR promoter. Our results indicate an important role of PS/gamma-secretase-generated APP metabolite AICD in gene transcription and in EGFR-mediated tumorigenesis.</value>
    </field>
    <field name="author">
      <value>Yun-wu Zhang</value>
    </field>
    <field name="author">
      <value>Ruishan Wang</value>
    </field>
    <field name="author">
      <value>Qiang Liu</value>
    </field>
    <field name="author">
      <value>Han Zhang</value>
    </field>
    <field name="author">
      <value>Francesca-Fang Liao</value>
    </field>
    <field name="author">
      <value>Huaxi Xu</value>
    </field>
    <field name="mesh">
      <value>Protein Processing, Post-Translational</value>
    </field>
    <field name="modified">
      <value>2/14/09</value>
    </field>
    <field name="LuceneDocID">
      <value>10424832</value>
    </field>
  </doc>
</aid:result>